Sunshine Biopharma Inc. Prepaid Expense, Current
Sunshine Biopharma Inc. (SBFM) had Prepaid Expense, Current of $478.49 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense, Current $478.49K.
- 2026-03-31: Prepaid Expense, Current $618.36K.
- 2025-12-31: Prepaid Expense, Current $798.38K.
- 2025-09-30: Prepaid Expense, Current $441.49K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2026-06-30 | $478.49K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $618.36K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $798.38K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $441.49K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $939.44K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $983.54K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.13M 10-K · filed 2026-04-03 |
| 2024-09-30 | $735.80K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $1.78M 10-Q/A · filed 2024-08-20 |
| 2024-03-31 | $871.39K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $310.59K 10-K · filed 2025-04-01 |
| 2023-09-30 | $37.56K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $107.02K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $152.26K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $283.80K 10-K · filed 2024-03-28 |
| 2022-09-30 | $27.39K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $48.56K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $38.63K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $29.63K 10-K · filed 2023-04-04 |
| 2021-09-30 | $25.05K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $15.69K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.99K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.78K 10-K · filed 2022-03-21 |
| 2020-09-30 | $5.11K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.41K 10-Q/A · filed 2020-08-31 |
| 2020-03-31 | $1.91K 10-Q · filed 2020-05-18 |
| 2019-12-31 | $1.25K 10-Q · filed 2020-11-12 |
| 2019-09-30 | $3.15K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.78K 10-Q · filed 2019-08-15 |
| 2019-03-31 | $3.74K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $1.34K 10-Q · filed 2019-11-13 |
| 2018-09-30 | $1.17K 10-Q · filed 2018-11-16 |
| 2018-06-30 | $1.09K 10-Q · filed 2018-08-17 |
| 2018-03-31 | $5.34K 10-Q · filed 2018-05-22 |
| 2017-12-31 | $9.67K 10-Q · filed 2018-11-16 |
| 2017-09-30 | $9.82K 10-Q · filed 2017-11-15 |
| 2017-06-30 | $8.54K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $846.00 10-Q · filed 2017-05-12 |
| 2016-12-31 | $1.01K 10-Q · filed 2017-11-15 |
| 2015-09-30 | $11.41K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $11.59K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-04 |
| 2014-09-30 | $6.42K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $5.64K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.34K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $0.00 10-Q · filed 2014-11-12 |
| 2013-09-30 | $617.00 10-Q · filed 2013-11-04 |
| 2013-06-30 | $4.18K 10-Q · filed 2013-08-06 |
| 2013-03-31 | $3.04K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.15K 10-K · filed 2014-03-19 |
| 2012-09-30 | $12.63K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $45.74K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $45.74K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $45.74K 10-K · filed 2013-03-15 |
| 2011-09-30 | $45.74K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $41.27K 10-Q · filed 2011-08-09 |
| 2011-03-31 | $41.27K 10-Q · filed 2011-05-12 |
| 2010-12-31 | $45.23K 10-K · filed 2012-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |